Clinical Trial Update: Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating second curettage for persistent non-metastatic gestational trophoblastic tumors, including complete and partial hydatidiform…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Trophoblastic Neoplasia
• Hydatidiform Mole Complete
• Hydatidiform Mole Partial

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Complete Hydatidiform Mole, Non-Metastatic Gestational Trophoblastic Tumor | Phase 2 | Status: COMPLETED